PHARMACOLOGICAL THERAPIES IN DEMENTIA

Citation
Kc. Fleming et Jm. Evans, PHARMACOLOGICAL THERAPIES IN DEMENTIA, Mayo Clinic proceedings, 70(11), 1995, pp. 1116-1123
Citations number
47
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00256196
Volume
70
Issue
11
Year of publication
1995
Pages
1116 - 1123
Database
ISI
SICI code
0025-6196(1995)70:11<1116:PTID>2.0.ZU;2-V
Abstract
Objective: To review past and current pharmacologic therapies for cogn itive and behavioral problems in elderly patients with dementia. Desig n: We surveyed the pertinent medical literature and present detailed f indings on results of pharmacotherapeutic interventions for cognitive loss and behavioral disorders. Results: Numerous drugs have been used in an attempt to reverse or forestall the cognitive decline associated with dementia, Currently available agents are limited by either lack of efficacy or occurrence of adverse effects. Medications are also use d to control undesirable behaviors associated with dementia. Depending on the individual circumstance, such pharmacologic therapies may be o f limited utility, some may be harmful, and others may be effective, T he use of psychotropic agents in nursing homes is strictly regulated b y federal law, For appropriate case of elderly patients with dementia, knowledge of the available drug therapies and their effectiveness is necessary. Conclusion: Drug therapies for dementia are associated with adverse effects in the elderly population, Drugs for management of ag gressive behaviors associated with dementia should be used only when n on-drug strategies have failed, In each patient with dementia, underly ing cognitive and behavioral problems must be thoroughly evaluated for selection of the most appropriate drug.